Sign inJoin waitlistJoin the waitlist

AF

Anna Farago

Assistant Professor, Medicine, Harvard Medical School · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present

Hematology and Medical Oncology
Mass General Brigham
2011–2014
Internal Medicine
Mass General Brigham
2008–2011
Harvard Medical School
2004–2008

Research

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
New England Journal of Medicine · 2018 · 2,193 citations
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
The Lancet Oncology · 2020 · 1,363 citations
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Clinical Cancer Research · 2016 · 1,124 citations

Alice Shaw
17 papers
Lecia Sequist
11 papers
ZP
Zofia Piotrowska
11 papers · 1 as a fellow
Benjamin Drapkin
10 papers · 6 as a fellow
JG
Justin Gainor
10 papers
MM
Mari Mino-Kenudson
10 papers
AH
Aaron Hata
9 papers
AD
Alexander Drilon
8 papers
Anthony Iafrate
8 papers
ID
Ibiayi Dagogo-Jack
7 papers · 4 as a fellow
SD
Subba Digumarthy
7 papers
CH
Christine Hann
6 papers

Grants

Using Patient-Derived Models to Understand Drug Responses in SCLC
National Cancer Institute · U01
PI · $1.2M · Massachusetts General Hospital
2018–2023

Clinical trials

Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
Principal investigator · Unknown · Phase 1, Phase 2
Zofia Piotrowska
2015–2023